Carleen Ann Irwin

Title: Carleen Ann Irwin: Innovator in Neurological Treatments

Introduction

Carleen Ann Irwin is a prominent inventor based in Chestnut Hill, MA (US). She has made significant contributions to the field of neurological treatments, holding 2 patents that focus on innovative methods and compositions for addressing neurological disorders.

Latest Patents

Her latest patents include "Methods and compositions for treatment of neurological disorder," which provides methods for producing a neurosalutary effect in subjects with conditions such as retinal and optic nerve damage. This method involves administering a therapeutically effective amount of a hexose, such as mannose. Another notable patent is "Trophic factors for central nervous system regeneration," which details cell culture conditions that maintain nerve cells of the retina in serum-free environments. This research identifies molecular factors that stimulate axonal regeneration, including two key molecules released by glial sheath cells, known as axogenesis factor 1 (AF-1) and axogenesis factor 2 (AF-2).

Career Highlights

Carleen is associated with the Children's Medical Center Corporation, where she continues her groundbreaking work in neurological research. Her innovative approaches have the potential to significantly impact the treatment of spinal cord and other nervous tissue damage.

Collaborations

Throughout her career, Carleen has collaborated with esteemed colleagues such as Larry I Benowitz and Paul Jackson, further enhancing the scope and impact of her research.

Conclusion

Carleen Ann Irwin's contributions to the field of neurological treatments exemplify her dedication to innovation and research. Her patents reflect a commitment to improving the lives of individuals affected by neurological disorders.